Study Finds Low Vitamin D Levels In Young People Of Color
July 14, 2022
Austria Scraps COVID Vaccine Mandate
July 14, 2022

Resveratrol Cuts Hospitalization Rate For COVID Outpatients

News

“A pilot study has found that resveratrol in combination with vitamin D3 lowered the rate of hospitalization among a cohort of subjects who tested positive for COVD-19.” [Source: nutraingredients-usa.com]

Comment

Resveratrol is a phytobiological that is present in very high concentrations in grapes, red wine and purple grape juice, and in smaller amounts in peanuts, blueberries, bilberries, cranberries, and dark chocolate. Even prior to this latest study, research had already demonstrated that it has potential as an antiviral against COVID-19.

The micronutrient that resveratrol was used in combination with in this study, vitamin D, has also previously been shown to be effective against COVID-19. A study published in 2021 by Spanish doctors found that, if given early enough, high-dose vitamin D can cut the risk of death in hospitalized coronavirus patients by a dramatic 60 percent. Patients given vitamin D were also found to be 80 percent less likely to need intensive care treatment.

To learn how scientists at the Dr. Rath Research Institute have demonstrated the efficacy of a specific combination of plant extracts and micronutrients against the original SARS-CoV-2 coronavirus and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants, see this article on our website.